Drugdu.com expert's response:

To efficiently conduct stability studies of in vitro diagnostic reagents within the framework of the EU's In Vitro Diagnostic Regulation (IVDR), it is essential to systematically advance from five perspectives: regulatory compliance, study design, implementation and execution, data management and analysis, and continuous improvement. The specifics are as follows:

1. Regulatory Compliance: Precisely Align with IVDR Requirements

Core Regulations and Guidelines:

IVDR Regulation: As the cornerstone of EU regulations for in vitro diagnostic reagents, IVDR specifies the fundamental requirements for stability studies, including study objectives, types, and data submission.

EN ISO 23640:2015: This standard provides detailed guidelines for the stability evaluation of in vitro diagnostic reagents, covering experimental design, evaluation procedures, and reporting requirements, serving as a crucial reference for stability studies.

CLSI EP25-A: Targeting quantitative/qualitative reagents, CLSI EP25-A encompasses the design of stability testing plans, data analysis, transportation assessment, and the application of accelerated testing, offering specific methods for quantitative reagent studies.

Key Requirements:

Types of Stability Studies: These include real-time stability, accelerated stability, transportation stability, and in-use stability (e.g., open-vial stability, reconstitution stability, on-board stability).

Data Submission: During registration, it is necessary to submit real-time stability study data for at least three batches of the declared product stored under actual conditions until the end of the stated shelf life, specifying storage conditions (temperature, humidity, light) and the shelf life.

Labeling and Instructions: Clearly indicate storage conditions, shelf life, and usage precautions under special circumstances (e.g., "Use within 24 hours after opening").

2. Study Design: Scientifically Plan the Research Path

Clear Study Objectives:

Determine the storage, transportation, and post-opening storage conditions for the product.

Establish the shelf life and post-opening shelf life of the product.

Validate the stability of the product after changes in storage conditions or shelf life.

Evaluate and adjust product formulation, process, and packaging materials based on stability study results.

Selection of Study Types:

Real-time Stability: Track long-term changes in reagent performance under the storage conditions stated on the product label, typically setting time points at 0, 3, 6, 9, 12, 18, and 24 months.

Accelerated Stability: Accelerate reagent degradation through extreme conditions such as high temperature and humidity to predict long-term stability trends and assist in determining shelf life. Cross-validate with real-time stability data to avoid excessive extrapolation.

Transportation Stability: Simulate actual transportation processes (e.g., vibration, temperature fluctuations, pressure changes) to verify reagent tolerance. Typically simulate long transportation times (e.g., 72 hours) to cover domestic inter-provincial or international transportation scenarios.

In-use Stability: Include open-vial stability, reconstitution stability, and on-board stability, simulating usage scenarios after reagent opening or reconstitution to verify performance changes over time.

Batch and Sample Selection:

Use at least three independently produced batches for stability studies to cover batch-to-batch variability.

Select batches that cover production scales (e.g., pilot, medium-scale, commercial batches).

Use representative samples (e.g., high, medium, and low concentration quality controls) to cover the clinical testing range.

3. Implementation and Execution: Strictly Control the Research Process

Environmental Control:

Ensure that stability studies are conducted in equipment such as constant temperature and humidity chambers, refrigerators, and humidity chambers to simulate actual storage conditions.

Continuously monitor temperature and humidity during transportation to ensure the accuracy of transportation stability studies.

Operational Norms:

Blind-code stability samples to avoid subjective bias from operators.

Record all raw detection data (e.g., absorbance values, Ct values) and attach spectra or photographs (e.g., gel electrophoresis images).

Use electronic data capture systems (EDCs) to ensure data traceability.

Deviation Handling:

If data at a certain time point is abnormal, initiate a deviation investigation (e.g., whether due to operational errors or reagent contamination).

For critical deviations (e.g., performance indicators exceeding acceptance criteria), immediately stop the experiment and investigate the cause; for minor deviations (e.g., slight discoloration in appearance), record and assess the impact on performance.

4. Data Management and Analysis: Scientifically Evaluate Research Results

Data Trend Analysis:

Use repeated measures analysis of variance (RM-ANOVA) or control charts (e.g., Xbar-R charts) to monitor performance trends.

Set warning limits (e.g., ±10%) and action limits (e.g., ±15%) to trigger deviation investigations.

Application of Statistical Methods:

Use linear regression, t-tests, and other statistical methods to determine whether performance indicators exceed preset acceptance criteria (e.g., ±10% deviation).

For accelerated stability data, establish mathematical models (e.g., Arrhenius equation) between accelerated and real-time conditions to extrapolate real-time shelf life and validate model applicability.

Report Compilation:

The stability study report should include study objectives, methods, results, conclusions, and deviation handling records.

The final report must be signed by the researcher and reviewed by the quality department.

5. Continuous Improvement: Optimize Research Processes and Methods

Modular Research: Divide stability studies into multiple modules (e.g., real-time, accelerated, transportation) and conduct them in parallel to shorten the cycle.

Application of Automated Equipment: Use stability test chambers (with temperature and humidity monitoring) and automated detection equipment (e.g., high-throughput chemiluminescence analyzers) to reduce human error.

Optimization During the R&D Phase: Identify reagent sensitivity factors through forced degradation tests (e.g., light exposure, oxidation) during the R&D phase and optimize formulations (e.g., adding stabilizers).

Tracking Regulatory Updates: Monitor stability study guideline updates released by regulatory agencies such as NMPA, FDA, and EMA, and adjust research plans accordingly.